Progesterone receptor isoform ratio dictates antiprogestin/progestin effects on breast cancer growth and metastases: A role for NDRG1-Reference-Cited by-同舟云学术

Progesterone receptor isoform ratio dictates antiprogestin/progestin effects on breast cancer growth and metastases: A role for NDRG1

Published:2022-01-13 Issue: Volume: Page:
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Intl Journal of Cancer

Author:

Abascal María Florencia¹,Elia Andrés¹,Alvarez Michelle¹²,Pataccini Gabriela¹,Sequeira Gonzalo¹³,Riggio Marina¹,Figueroa Virginia¹,Lamb Caroline A.¹,Rojas Paola A.¹,Spengler Eunice⁴,Martínez‐Vazquez Paula⁴,Burruchaga Javier⁴,Liguori Marcos⁴,Sahores Ana¹,Wargon Victoria¹,Molinolo Alfredo⁵,Hewitt Stephen⁶,Lombes Marc⁷,Sartorius Carol⁸,Vanzulli Silvia Inés⁹,Giulianelli Sebastián¹¹⁰^ORCID,Lanari Claudia¹^ORCID

Affiliation:

1. Instituto de Biología y Medicina Experimental (IBYME) CONICET Buenos Aires Argentina

2. Facultad de Farmacia y Bioquímica Universidad de Buenos Aires Buenos Aires Argentina

3. Hospital Público de Gestión Descentralizada Dr. Arturo Oñativia Salta Argentina

4. Hospital de Agudos “Magdalena V de Martínez” General Pacheco Buenos Aires Argentina

5. Moores Cancer Center UCSD La Jolla California USA

6. National Cancer Institute NIH Bethesda Maryland USA

7. INSERM and Fac Med Paris‐Sud Université Paris Saclay, UMR‐S 1185 Le Kremlin‐Bicêtre France

8. Department of Medicine University of Colorado, Anschutz Medical Campus Aurora Colorado USA

9. Academia Nacional de Medicina Buenos Aires Argentina

10. Instituto de Biología de Organismos Marinos IBIOMAR‐CCT CENPAT‐CONICET Puerto Madryn Argentina

Funder

Agencia Nacional de Promoción Científica y Tecnológica

Instituto Nacional del Cáncer

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ijc.33913

Reference54 articles.

1. Locally recurrent or metastatic breast cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow‐up;Cardoso F;Ann Oncol,2012

2. Breast cancer treatment: a review;Waks AG;JAMA,2019

3. Selective progesterone receptor modulators in early stage breast cancer: a randomized, placebo‐controlled phase II window of opportunity trial using telapristone acetate;Lee O;Clin Cancer Res,2019

4. Progesterone receptors in normal breast development and breast cancer;Giulianelli S;Essays Biochem,2021

5. The antiprogestin RU486 in advanced breast cancer: preliminary clinical trial;Romieu G;Bull Cancer,1987

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antiprogestins for breast cancer treatment: We are almost ready;The Journal of Steroid Biochemistry and Molecular Biology;2024-07

2. NDRGs in Breast Cancer: A Review and In Silico Analysis;Cancers;2024-03-29

3. A Comparison of the Malignant Behavior of Asian and Caucasian Colorectal Cancer Cell Lines in Vitro and in Vivo;World Journal of Cancer Research;2024

4. Expression Characteristics of NDRG1 and nm23 in Laryngeal Squamous Cell Carcinoma and Their Effects on the Patient’s Prognosis;Advances in Clinical Medicine;2024

5. Molecular characterization of breast cancer cell pools with normal or reduced ability to respond to progesterone: a study based on RNA-seq;Journal of Genetic Engineering and Biotechnology;2023-12